The company is establishing commercial production capabilities to fuel plans to launch autologous CAR-T cell therapies in China.

Following through with its sizable investment commitment in China, AstraZeneca on Thursday unveiled plans to build a commercial cell therapy manufacturing base and an innovation center dedicated to | ...

British drugmaker AstraZeneca Plc has emerged as the leading contender to acquire French biotech Abivax SA, following the ...

Everyone’s favorite bracket challenge has returned. That’s right—it’s time once again for Fierce Pharma Marketing’s annual ...

GRANTS PASS, OR / ACCESS Newswire / March 16, 2026 / Venture capitalist and biotech entrepreneur Andrew Hamilton, through his investment firm Pale Horse Capital, has acquired the premium ...

UK pharma major AstraZeneca’s majority owned Indian subsidiary, today announced that Central Drugs Standard Control Organization (CDSCO) has approved an additional indication for durvalumab solution ...

GRANTS PASS, OR / ACCESS Newswire / March 16, 2026 / Venture capitalist and biotech entrepreneur Andrew Hamilton, through his ...

AstraZeneca’s Imfinzi (durvalumab) in combination with standard-of-care FLOT chemotherapy (fluorouracil, leucovorin, oxaliplatin, and docetaxel) has been approved in the European Union (EU) for the ...

Exxon Mobil, Palantir and AstraZeneca lead Zacks' latest analyst reports, highlighting strong production growth, AI momentum and a robust drug pipeline.

Stelios Tzellos Highlights The Growing Convergence Of Real-World Evidence And Commercial Strategy In Pharma. EINPresswire/ -- Stelios Tzellos, Ph.D., a UK-based pharmaceutical analytics professional ...

Jurors from GE, Philips, AstraZeneca, Apollo Hospitals, NHS, IQVIA, Frost & Sullivan, and other global leaders ...

FRANKFURT, March 9 (Reuters) - Roche's shares dropped more than 7% at one stage on Monday, their biggest decline in nearly a ...